Baluch Khoso — SEC Form 4 filings
SEC reporting owner CIK 1686223. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-28.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-06-11 to 2026-07-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 14,035 shares, $5,752 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,250 shares, $2,588 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 2,269 shares @ $2.54 ($5,752) in Processa Pharmaceuticals, Inc., filed 2026-04-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | Director | 7 | 1 leg · 2,269 sh · $5,752 | — | 8 |
| Longeveron Inc. (LGVN) | Director | 5 | 1 leg · 11,766 sh | 1 leg · 1,250 sh · $2,588 | 4 |
Form 4 filings — Baluch Khoso
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-28 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Option exercise (M): 203 · Option exercise (M): 203 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 2,269 @ $2.54 | EDGAR |
| 2025-10-03 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-09-18 | 4/A | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 31,206 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | Longeveron Inc. (LGVN) | Purchase (P): 11,766 · Purchase (P): 29,415 (derivative) | EDGAR |
| 2025-07-28 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 175,299 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | Longeveron Inc. (LGVN) | Grant/award (A): 17,000 @ $0 | EDGAR |
| 2024-12-04 | 4 | Longeveron Inc. (LGVN) | Sale (S): 1,250 @ $2.07 | EDGAR |
| 2024-09-18 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 31,206 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | Longeveron Inc. (LGVN) | Grant/award (A): 23,500 @ $0 | EDGAR |
| 2024-06-11 | 4 | Longeveron Inc. (LGVN) | Tax withholding (F): 125 @ $1.06 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1686223 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →